Literature DB >> 19706819

Blood flow-metabolism mismatch: good for the tumor, bad for the patient.

David A Mankoff1, Lisa K Dunnwald, Savannah C Partridge, Jennifer M Specht.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19706819      PMCID： PMC2941711          DOI： 10.1158/1078-0432.CCR-09-1448

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  11 in total

1.  How do cancer cells acquire the fuel needed to support cell growth?

Authors:  C B Thompson; D E Bauer; J J Lum; G Hatzivassiliou; W-X Zong; F Zhao; D Ditsworth; M Buzzai; T Lindsten
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005

Review 2.  Antiangiogenic therapy for cancer: current and emerging concepts.

Authors:  Rakesh K Jain
Journal:  Oncology (Williston Park)       Date:  2005-04       Impact factor: 2.990

Review 3.  PET contributions to understanding normal and abnormal cardiac perfusion and metabolism.

Authors:  H R Schelbert
Journal:  Ann Biomed Eng       Date:  2000-08       Impact factor: 3.934

4.  18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy.

Authors:  Jeffrey Tseng; Lisa K Dunnwald; Erin K Schubert; Jeanne M Link; Satoshi Minoshima; Mark Muzi; David A Mankoff
Journal:  J Nucl Med       Date:  2004-11       Impact factor: 10.057

5.  The relationship between vascular and metabolic characteristics of primary breast tumours.

Authors:  Scott I K Semple; Fiona J Gilbert; Thomas W Redpath; Roger T Staff; Trevor S Ahearn; Andrew E Welch; Steven D Heys; Andrew W Hutcheon; Elizabeth H Smyth; Shailesh Chaturvedi
Journal:  Eur Radiol       Date:  2004-08-14       Impact factor: 5.315

6.  Decreased blood flow with increased metabolic activity: a novel sign of pancreatic tumor aggressiveness.

Authors:  Gaber Komar; Saila Kauhanen; Kaisa Liukko; Marko Seppänen; Sami Kajander; Jari Ovaska; Pirjo Nuutila; Heikki Minn
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

Review 7.  Matching coronary blood flow to myocardial oxygen consumption.

Authors:  Johnathan D Tune; Mark W Gorman; Eric O Feigl
Journal:  J Appl Physiol (1985)       Date:  2004-07

8.  The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry.

Authors:  Fionnuala Morrish; Nicola Neretti; John M Sedivy; David M Hockenbery
Journal:  Cell Cycle       Date:  2008-02-08       Impact factor: 4.534

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

Review 10.  Warburg revisited: imaging tumour blood flow and metabolism.

Authors:  K A Miles; R E Williams
Journal:  Cancer Imaging       Date:  2008-03-25       Impact factor: 3.909
View more
  19 in total

1.  A comparison study of dual-energy spectral CT and 18F-FDG PET/CT in primary tumors and lymph nodes of lung cancer.

Authors:  Osman Kupik; Yavuz Metin; Gülnihan Eren; Nurgul Orhan Metin; Medeni Arpa
Journal:  Diagn Interv Radiol       Date:  2021-03       Impact factor: 2.630

2.  Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.

Authors:  Savannah C Partridge; Risa K Vanantwerp; Robert K Doot; Xiaoyu Chai; Brenda F Kurland; Peter R Eby; Jennifer M Specht; Lisa K Dunnwald; Erin K Schubert; Constance D Lehman; David A Mankoff
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

3.  Multiparametric and Multimodality Functional Radiological Imaging for Breast Cancer Diagnosis and Early Treatment Response Assessment.

Authors:  Michael A Jacobs; Antonio C Wolff; Katarzyna J Macura; Vered Stearns; Ronald Ouwerkerk; Riham El Khouli; David A Bluemke; Richard Wahl
Journal:  J Natl Cancer Inst Monogr       Date:  2015-05

4.  Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion.

Authors:  Hsin-Yu Chen; Peder E Z Larson; Robert A Bok; Cornelius von Morze; Renuka Sriram; Romelyn Delos Santos; Justin Delos Santos; Jeremy W Gordon; Naeim Bahrami; Marcus Ferrone; John Kurhanewicz; Daniel B Vigneron
Journal:  Cancer Res       Date:  2017-04-20       Impact factor: 12.701

5.  Biological correlates of tumor perfusion and its heterogeneity in newly diagnosed breast cancer using dynamic first-pass 18F-FDG PET/CT.

Authors:  Neree Payan; Benoit Presles; François Brunotte; Charles Coutant; Isabelle Desmoulins; Jean-Marc Vrigneaud; Alexandre Cochet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-08       Impact factor: 9.236

6.  Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer.

Authors:  Jennifer M Specht; Brenda F Kurland; Susan K Montgomery; Lisa K Dunnwald; Robert K Doot; Julie R Gralow; Georgina K Ellis; Hannah M Linden; Robert B Livingston; Kimberly H Allison; Erin K Schubert; David A Mankoff
Journal:  Clin Cancer Res       Date:  2010-05-11       Impact factor: 12.531

7.  Hyperpolarized (13)C spectroscopy detects early changes in tumor vasculature and metabolism after VEGF neutralization.

Authors:  Sarah E Bohndiek; Mikko I Kettunen; De-en Hu; Kevin M Brindle
Journal:  Cancer Res       Date:  2012-01-05       Impact factor: 12.701

8.  Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer.

Authors:  Anna G Sorace; Anum K Syed; Stephanie L Barnes; C Chad Quarles; Violeta Sanchez; Hakmook Kang; Thomas E Yankeelov
Journal:  Mol Imaging Biol       Date:  2017-02       Impact factor: 3.488

Review 9.  Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow.

Authors:  Robert J Gillies; Joel S Brown; Alexander R A Anderson; Robert A Gatenby
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

10.  Combined measurement of tumor perfusion and glucose metabolism for improved tumor characterization in advanced cervical carcinoma. A PET/CT pilot study using [15O]water and [18F]fluorodeoxyglucose.

Authors:  I Apostolova; F Hofheinz; R Buchert; I G Steffen; R Michel; C Rosner; V Prasad; C Köhler; T Derlin; W Brenner; S Marnitz
Journal:  Strahlenther Onkol       Date:  2014-02-18       Impact factor: 3.621
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.